HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
HIV prevention boost: 30,000 people in kenya to get PrEP through family planning clinics
Prevention Recruiting nowThis study tests a new way to deliver HIV prevention medicine (PrEP) by having HIV testing counselors lead PrEP care in family planning clinics in Kenya. About 30,000 people aged 15 and older who visit these clinics will take part. The goal is to see if this approach helps more p…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated May 26, 2026 11:18 UTC
-
Yearly HIV shot could replace daily pills
Prevention Recruiting nowThis study tests a new shot given once a year to prevent HIV. It is for people who are at risk of getting HIV. The shot uses a drug called lenacapavir, and researchers want to see if it is safe and how well it works over 12 months. About 350 people will take part.
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Prevention
Last updated May 26, 2026 11:15 UTC
-
Monthly pill could replace daily HIV prevention
Prevention Recruiting nowThis study tests a new once-monthly pill (MK-8527) to see if it works as well as the standard daily pill for preventing HIV-1 infection. About 4,390 HIV-negative adults who are at risk of HIV will take either the monthly pill or a daily pill for up to 18 months. Researchers will …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 26, 2026 11:13 UTC
-
Monthly pill could revolutionize HIV prevention for women
Prevention Recruiting nowThis study tests a new monthly pill (MK-8527) to see if it works better than a daily pill for preventing HIV in women. About 4,580 HIV-negative women who are sexually active will take either the monthly pill or a daily standard PrEP pill. The goal is to find a simpler, effective …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
New injectable PrEP study aims to boost HIV prevention in latine communities
Prevention Recruiting nowThis study tests a culturally-tailored program offering long-acting injectable PrEP (lenacapavir) to 100 Latine gay, bisexual men, and transgender women in the southern U.S. The goal is to see if this community-delivered approach helps more people start and stay on PrEP compared …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated May 18, 2026 12:03 UTC